Assenagon Asset Management S.A. Makes New $15.67 Million Investment in Maximus, Inc. $MMS

Assenagon Asset Management S.A. purchased a new position in shares of Maximus, Inc. (NYSE:MMS) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 181,565 shares of the health services provider’s stock, valued at approximately $15,673,000.

Several other hedge funds have also recently modified their holdings of the stock. Norges Bank purchased a new stake in Maximus during the 2nd quarter worth approximately $47,886,000. Boston Partners raised its holdings in shares of Maximus by 113.6% in the second quarter. Boston Partners now owns 657,247 shares of the health services provider’s stock worth $46,435,000 after buying an additional 349,529 shares during the last quarter. River Road Asset Management LLC purchased a new position in shares of Maximus in the second quarter worth $18,073,000. Stephens Investment Management Group LLC lifted its stake in shares of Maximus by 49.0% during the third quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider’s stock worth $65,873,000 after buying an additional 237,097 shares during the period. Finally, Voya Investment Management LLC grew its holdings in shares of Maximus by 1,380.3% during the third quarter. Voya Investment Management LLC now owns 228,488 shares of the health services provider’s stock valued at $20,877,000 after buying an additional 213,053 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Stock Performance

Shares of NYSE MMS opened at $66.03 on Friday. The company has a current ratio of 2.34, a quick ratio of 2.34 and a debt-to-equity ratio of 0.88. Maximus, Inc. has a 12 month low of $64.68 and a 12 month high of $100.00. The company has a 50 day simple moving average of $79.89 and a two-hundred day simple moving average of $84.49. The stock has a market cap of $3.60 billion, a price-to-earnings ratio of 10.05 and a beta of 0.59.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same quarter in the prior year, the business earned $1.61 earnings per share. The business’s quarterly revenue was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were given a dividend of $0.33 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.32 annualized dividend and a yield of 2.0%. This is an increase from Maximus’s previous quarterly dividend of $0.30. Maximus’s payout ratio is 20.09%.

Insiders Place Their Bets

In related news, CEO Bruce Caswell bought 3,175 shares of the stock in a transaction dated Tuesday, February 10th. The shares were purchased at an average price of $78.45 per share, for a total transaction of $249,078.75. Following the completion of the purchase, the chief executive officer directly owned 328,013 shares of the company’s stock, valued at $25,732,619.85. This represents a 0.98% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO David Mutryn bought 1,000 shares of the company’s stock in a transaction that occurred on Monday, February 9th. The shares were bought at an average cost of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the acquisition, the chief financial officer owned 40,037 shares of the company’s stock, valued at $3,027,597.94. This trade represents a 2.56% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 1.80% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on MMS shares. Zacks Research raised Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Finally, Weiss Ratings downgraded Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research note on Tuesday, February 24th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy”.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.